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Abstract
Acute pancreatitis has a broad clinical spectrum: from mild, self-limited disease 
to fulminant illness resulting in multi-organ failure leading to a prolonged clinical 
course with up to 30% mortality in case of infected necrosis. Management of local 
complications such as pseudocysts and walled-off necrosis may vary from clinical 
observation to interventional treatment procedures. Gram negative bacteria infec-
tion may develop in up to one-third of patients with pancreatic necrosis leading to a 
clinical deterioration with the onset of the systemic inflammatory response syn-
drome and organ failure. When feasible, an interventional treatment is indicated. 
Percutaneous or endoscopic drainage approach are the first choices. A combination 
of minimally invasive techniques (step-up approach) is possible in patients with 
large or multiple collections. Open surgical treatment has been revised both in the 
timing and in the operating modalities in the last decades. Since 1990s, the surgical 
treatment of infected necrosis shifted to a more conservative approach. Disruption 
of the main pancreatic duct is present in up to 50% of patients with pancreatic fluid 
collections. According to the location along the Wirsung, treatment may vary from 
percutaneous drainage, endoscopic retrograde pancreatography with sphincterec-
tomy or stenting to traditional surgical procedures. Patients may suffer from vascu-
lar complications in up to 23% of cases. Tissue disruption provoked by lipolytic and 
proteolytic enzymes, iatrogenic complications during operative procedures, splenic 
vein thrombosis, and pseudoaneurysms are the pathophysiological determinants of 
bleeding. Interventional radiology is the first line treatment and when it fails or is 
not possible, an urgent surgical approach should be adopted. Chylous ascites, biliary 
strictures and duodenal stenosis are complications that, although uncommon and 
transient, may have different treatment modalities from non-operative, endoscopic 
to open surgery.
Keywords: pancreatic pseudocysts, walled-off necrosis, infected pancreatic necrosis, 
disconnected pancreatic duct syndrome, vascular complications, chylous ascites
1. Introduction
The majority of patients suffering from acute pancreatitis will have a mild, 
self-limited and uncomplicated course. Pancreatic necrosis may develop in up to 
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10%-20% of patients, because of insufficient perfusion of pancreatic parenchyma 
to support metabolic requirements, leading to a prolonged clinical course with up 
to 30% mortality in case of infected necrosis [1]. Local and systemic complications, 
mild or life-threatening, such as pancreatic and/or peripancreatic fluid collections, 
walled-off necrosis, infected pancreatic necrosis, disconnected pancreatic duct syn-
drome and vascular complications can occur. The successful management of these 
patients needs a multidisciplinary team composed by gastroenterologists, surgeons, 
interventional radiologists, and specialists in critical care medicine, infectious 
disease, and nutrition. Intervention is generally required for infected pancreatic 
necrosis and less commonly in patients with sterile necrosis who are symptomatic 
(gastric or duodenal outlet or biliary obstruction) [2]. The surgical odyssey in man-
aging necrotizing pancreatitis is a notable example of how evidence-based knowl-
edge leads to improvement in patient care. Open surgical necrosectomy has been the 
traditional surgical treatment for years. However, although it provides a wide access 
but it is associated with high morbidity (34%-95%) and mortality (11-39%). In the 
last decades treatment has moved towards minimally invasive techniques: laparos-
copy, retroperitoneal and endoscopic or percutaneous approaches. These can allow 
open surgery to be postponed in a sub-acute setting or even to avoid it [3–6].
2. Pancreatic necrosis and pseudocysts
Local complications such as pancreatic and/or peripancreatic fluid collections 
can occur after an episode of acute pancreatitis or after recrudescence of chronic 
pancreatitis or a blunt, penetrating, iatrogenic pancreatic trauma. Peripancreatic 
fluid collections, with or without a necrotic component, are early manifestations 
of the pancreatic inflammatory process. They are not delimited by a well-defined 
inflammatory wall and often remain asymptomatic, ending in spontaneous resolu-
tion by a gradual reduction in size. After four weeks from the clinical manifestation, 
persistent collections usually become wall-defined, encapsulated, with (walled-off 
necrosis) or without (pancreatic pseudocyst) a necrotic component and a varying 
degree of pancreatic parenchyma involvement [7].
Management of pseudocysts and walled-off pancreatic necrosis (WOPN) rely 
on patient’s symptoms, location and characteristics of pancreatic and/or peripan-
creatic collections, local complications (such as pseudoaneurysm), expertise and 
availability of a multidisciplinary group [8].
In asymptomatic patients, clinical observation and periodic imaging follow 
up (every three-six months) represent the most successful management, due to 
the frequent reduction in size and spontaneous resolution of non-complicated 
homogeneous collections and to the morbidity associated to interventional (endo-
scopic or radiologic) treatment procedures. In these cases, it is possible to associate 
nutritional and pharmacological support (nasoenteric feeding reduces pain and 
improves nutritional status; proton pump inhibitors and somatostatin-analogue 
such as octreotide reduce pancreatic secretion).
Infection will develop in about one third of patients with pancreatic necrosis. 
It may arise at any time during the clinical course but peak incidence is between 
the 2nd and the 4th week after presentation [2]. Gram-negative bacteria are the 
main infectious species isolated, the most common of which are Escherichia coli 
and Pseudomonas aeruginosa [9]. Recently, a trend towards increasing incidence of 
Gram-positive and multi-resistant bacteria has been demonstrated [10, 11].
Prognosis and management are greatly affected by the recognition between 
sterile and infected pancreatic necrosis. Clues of suspicion should arise in case of 
clinical signs of systemic inflammatory response syndrome (SIRS) (new-onset 
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fever, tachycardia, leukocytosis) or organ failure [12]. A blood culture with positive 
bacterial results and gas in and around the pancreas on a CT scan may give indirect 
evidence of infection. Prophylactic antibiotic use in patients suffering from acute 
pancreatitis has not been proven to decrease infection rate and thus, according to 
the meta-analysis by Wittau et al. [13] it is not recommended a routine prophylaxis. 
The Cochrane review by Villatoro et al. [14] showed that antibiotic prophylaxis 
was not associated with a reduced incidence of pancreatic necrosis infection, even 
though it was associated with significantly decreased mortality. CT- or US-guided 
fine needle aspiration of pancreatic necrosis for bacteriologic analysis are an accu-
rate, safe and reliable techniques with high accuracy (89.4%-100%) [15, 16].
In symptomatic patients, with rapidly enlarging pseudocysts or systemic 
manifestations of organ failure sustained by an infectious process, an interventional 
treatment is indicated. In this case endoscopic drainage approach is the first choice, 
especially when fluid collection is close to gastroduodenal lumen. A combination 
of techniques is possible in patients with large collections, extended in pelvis and 
paracolic gutters, or multiple collections [17].
2.1 Endoscopic drainage
Endoscopic drainage of a walled collection is the preferred method when the 
drainage criteria are met: mature collections delimited by a well-defined inflamma-
tory capsule and with a mostly liquid content; cystic wall adherent to stomach or 
duodenum; and collection’s size at least 6 cm in size.
This procedure has to be performed by an endoscopist with expertise and when 
surgical or interventional radiology staffs are available [18]. Contraindications 
to endoscopic drainage are: presence of pseudoaneurysm due to gastroduodenal 
or splenic artery erosion, with high risk of bleeding; and collections without a 
mature wall.
Drainage techniques consist in [19]: transmural drainage: creation of a passage 
through the stomach or duodenum wall into the cyst lumen. This permits cystic 
drainage after balloon dilatation and placement of one or more stents. This method 
is preferred to drain WOPN in order to evacuate solid debris. Transpapillary drain-
age: placement of a ductal pancreatic stent with or without preliminary sphinc-
terotomy to drain cysts in communication with pancreatic duct, especially when 
endoscopic retrograde pancreatography demonstrates ongoing ductal leak.
Transmural approach is adopted when large and symptomatic walled-off 
pancreatic fluid collection is close to gastroduodenal structures. Transmural 
puncture through gastroduodenal wall (where is endoscopically visible a bulge 
resulting by apposition to the cyst), is nowadays ecoendoscopically guided. This 
permits to accurately identify puncture site for cystenterostomy, avoiding vessels or 
other interposed structures and evaluating real distance to pass through [20]. Self-
expanding metal stents or plastic double pig-tail stents can be both used. Lumen 
Apposing Metal Stent (LAMS) are associated with higher bleeding grade but allow 
immediate procedures such as endoscopic necrosectomy.
Drainage of turbid necrotic fluid suggests debris presence and can be managed 
with direct endoscopic debridement and/or with the placement of a naso-cystic 
catheter for post-procedural lavage. Repeated debridement or association with 
percutaneous drainage or percutaneous endoscopic gastrostomy can be necessary 
with unresolved fluid collections [21].
For patients with small pseudocysts derived from main pancreatic duct, trans-
papillary stent placement is indicated as first drainage approach. This provides 
continuous drainage of pancreatic fluid, leading to resolution of pancreatic ductal 
disruption that is responsible of pseudocyst. Follow up with CT or EUS is preferred 
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after four to six weeks if necrotic debridement was not necessary and stents are then 
removed the fluid cavity is collapsed. More frequent imaging is obtained in patients 
who underwent necrosectomy, to determine if additional debridement is neces-
sary. When collections are completely evacuated, stents are removed. Long-term 
stents seem to protect against recurrence allowing ongoing drainage of pancreatic 
secretions, although cystenterostomy tract matures and persists after eventual stent 
removal [22].
2.2 Percutaneous drainage
Percutaneous drainage remains an important treatment modality for patients 
with symptomatic collections. It may be used both as primary therapy or as an 
adjunct to other techniques. According to the last International [23], American [1] 
and Japanese [24] guidelines, percutaneous catheter (or endoscopic transmural 
drainage) should be the first step in the treatment of patients with suspected 
or confirmed (walled-off) infected necrotizing pancreatitis. This is applied to 
decompress retroperitoneal fluid collections, to provide a rapid and effective means 
for source control in patients with infected pancreatic necrosis. It favors clinical 
stabilization of patients before endoscopic or surgical debridement and is the first 
choice when endoscopic drainage is unavailable, unsuccessful, or not technically 
feasible [25].
The positioning can be performed via the transperitoneal or retroperitoneal 
approaches. It is technically feasible in >95% of patients [26]. Retroperitoneal 
route is generally preferred because it avoids peritoneal contamination, enteric 
fistulas and facilitates a possible step-up approach (see “Surgical approach” chap-
ter). Moreover, the catheter tract can act as an entry portal for minimally invasive 
debridement methods, such as video assisted retroperitoneal or endoscopic 
debridement [1]. Catheters range from 8 Fr to 30 Fr in diameter; they allow for 
bedside irrigation and clearance of necrotic material, can be manipulated and 
replaced according to the evolution of the collections [27].
Percutaneous drainage alone may provide definitive therapy for a subset of 
patients. The prospective observational multicenter study by Horvath K. et al. in 
2010, found that the decrease in the size of the collection of at least 75% after the 
first 10-14 days predicts successful percutaneous treatment. In 2011, a large pro-
spective multicenter study of treatment outcomes among patients with necrotizing 
pancreatitis demonstrated that catheter drainage was the first intervention in 63% 
of cases and did not require additional necrosectomy in 35% of patients [28]. Two 
prospective randomized trials from the Dutch Pancreatitis Study Group compared 
various approaches to the management of symptomatic WON. They demonstrated 
that percutaneous drainage alone was successful in 35%-51% of patients and that a 
minimally invasive step-up approach was related to a lower rate of pancreatic fistu-
las, length of hospital stay and death, as compared with open necrosectomy [26, 29].
The risk of pancreatocutaneous fistula formation is the major potential draw-
back of this technique. The multicentre randomised trial by van Brunschot S. et 
al. demonstrated that the rate of pancreatic fistula formation was significantly 
higher in the percutaneous (32%) as compared to the video-assisted retroperitoneal 
debridement (VARD) group (5%) [29]. The rate is as high as 45% in those with 
disconnected duct syndrome [30].
2.3 Surgical approach
The surgical odyssey in managing necrotizing pancreatitis is a notable example 
of how evidence-based knowledge leads to improvement in patient care. In the 
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beginning of the 20th century surgeons such as Mayo Robson, Mickulicz, and 
Moynihan, in the context of the progression of anesthesia, were induced to deploy 
laparotomy in an effort to treat complications of severe acute pancreatitis [31]. Over 
the next decades surgical intervention became the therapy of choice despite a mor-
tality rate greater than 50%. Extensive pancreatic resection became the treatment 
of choice in the 1960s and 1970s. Innovations and increased accuracy in radiological 
techniques led to new approaches for management. Surgeons were divided between 
those who reserved the intervention for cases of infected necrosis by proposing 
delayed exploration, and those who proposed early debridement for all patients 
with necrotizing pancreatitis. Since 1990s several studies proved that nonoperative 
management of patients with sterile pancreatic necrosis was superior to surgical 
intervention, and that delayed intervention provided improved surgical mortality 
rates. The treatment of infected necrosis shifted to a more conservative approach 
also thanks to a comprehensive knowledge of the physio-pathological process of the 
systemic inflammatory response and the adoption of novel antibiotics in curb-
ing systemic toxicity and protecting against organ failure. Recently, endoscopic 
debridement and minimally invasive techniques has been introduced [31, 32].
The last guidelines of the Working Group of the International Association of 
Pancreatology (IAP)/American Pancreatic Association (APA) published in 2013 
[23] and of the American Gastroenterological Association (AGA) published in 
2020[1] on the management of acute pancreatitis and pancreatic necrosis list the 
common indications for intervention. A symptomatic sterile pancreatic necrosis 
is an indication for intervention (either radiological, endoscopical or surgical). 
Symptoms can be represented by: gastric, intestinal, or biliary obstruction due to 
the mass effect of walled-off necrosis, pain, persistent unwellness in patients with-
out signs of infection [1]. In case of infected pancreatic necrosis invasive procedures 
(e.g. percutaneous catheter drainage, endoscopic transluminal drainage/necrosec-
tomy, minimally invasive or open necrosectomy) should be delayed, where possible, 
until at least 4 weeks after initial presentation to permit the collection to become 
“walled-off”. A randomized clinical trial [33] that compared early surgery (within 
72 h) and delayed surgery (11 days after onset) demonstrated mortality rates of 
56% and 27%, respectively.
Percutaneous drainage, alone or in combination with other minimally invasive 
approaches, can be an effective means for source control in patients with infected 
pancreatic necrosis. A significant number of patients (23%–47%) will resolve their 
necrosis with percutaneous drainage alone. In those with persistent disease, a step 
up to operative intervention may be undertaken. The tract of the drain is utilized 
to access the retroperitoneal space for an intracavitary videoscopic necrosectomy 
by which drains are left in the cavity for lavage and fistula control [26, 34, 35]. The 
PANTER Study in 2010, a prospective randomized multicenter trial, compared 
the step-up approach to open necrosectomy and found a higher rate of new-onset 
multiple-organ failure in the open necrosectomy group (40% vs. 12%) and an 
equivalent mortality between the groups [26]. Surgical transgastric debridement 
is similar to endoscopic transgastric debridement, can be done laparoscopically or 
open, and is performed by an anterior gastrotomy to access the posterior wall of the 
stomach for transmural access to the necrosis cavity. Open surgical debridement is 
still an important resource in the management of these patients for the debridement 
of necrotic tissue.
Before surgical approach, abdominal imaging is helpful to determine intra-
abdominal status. Diagnosis of infected pancreatic necrosis is made by identi-
fication of air bubbles in retroperitoneal necrosis (areas with lack of contrast 
enhancement) on CT scan. Diagnosis can be confirmed by CT-guided fine needle 
aspiration of necrotic material for culture. CT is also indicated to define extent 
Pancreatitis
6
and location of necrotic areas, for example into the mesenteric root and down the 
paracolic gutters; to demonstrate the presence of a disconnected pancreatic segment 
(a viable pancreatic portion separated by the rest of pancreas by a necrotic segment, 
that require external drainage to create a controlled external pancreatic fistula); and 
to evaluate the presence of other local complications, such as gastric outlet obstruc-
tion, splenic or portal vein thrombosis and colonic necrosis. Open debridement 
with external drainage still plays an important, albeit limited, role. After access to 
retroperitoneum, fluid is evacuated and necrotic dissection and debridement is 
made. In biliary pancreatitis, cholecystectomy should be practiced but it is associ-
ated with increased incidence of postoperative bile leak or biliary injury. Colon 
resection and colostomy have to be considered if mesocolon is involved in peripan-
creatic necrosis. A feeding enteral tube and at least two-four drainage tubes should 
be placed [36].
Video-assisted retroperitoneal debridement approach requires preoperative 
percutaneous retroperitoneal access. Radiological catheter insertion is a route to 
guide the subsequent procedure directly down into necrotic cavity and postopera-
tive lavage. The advantage is minimizing the risk of peritoneal contamination, 
but the access is limited and precludes other procedures over debridement [34]. 
Postoperative complications are: intra-abdominal residual fluid collections, derived 
from pancreatic leak not well controlled by drains; bleeding, due to vascular lesion 
during debridement maneuvers or rupture of pseudoaneurysm, related to vascular 
erosion caused by mechanical drain damage or infection associated with uncon-
trolled pancreatic fistula; pancreatic fistulas: amylase-rich (concentration greater 
than three times the upper limit of normal serum amylase) fluid coming from 
drains; biliary injury; and pancreatic endocrine and exocrine insufficiency, that 
may requires supplemental insulin and oral pancreatic enzyme replacement.
Each approach has distinct peculiarities with pros and cons that must be 
weighted in each case planning: pattern of disease, physiology of the patient, 
expertise of the multidisciplinary team, and the resources of the center [1].
3. Disconnected pancreatic duct syndrome
The term disconnected pancreatic duct syndrome (DPDS) refers to a subset of 
patients suffering from a disruption of the main pancreatic duct leading to a normal 
upstream pancreatic gland having no communication with the gastrointestinal tract 
[1, 37]. Up to 50% of patients with pancreatic fluid collections might have an under-
lying disconnected duct. It is best recognized using secretin-stimulated magnetic 
resonance cholangiopancreatography [38]. DPDS can be the result of acute necro-
tizing pancreatitis, chronic pancreatitis, and pancreatic trauma. Pancreatic juice is 
still secreted from the disconnected gland resulting in different resolutions that are 
a continuum of the same pathophysiologic process: recurrent acute pancreatitis, 
internal persistent pancreatic fistula (most often presenting as a peripancreatic 
fluid collection), external fistula, pancreatic pleural effusion, pancreatic ascites, or 
disconnected pancreatic tail syndrome [39, 40].
Internal fistulae are the result of ductal disruptions that are not contained by 
the inflammatory response. Anterior ductal disruptions result in pancreatic ascites, 
posterior ones result in pancreatic pleural effusions. Positive testing for a collection 
rich in pancreatic enzyme gives the secure diagnosis. A percutaneous drainage is the 
initial treatment to obtain a controlled fistula that in 70-82% of cases results in a 
spontaneous closure.
External fistulae may develop after pseudocyst percutaneous drainage. The 
stricture or the obstruction of the Wirsung result in ductal hypertension thus 
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increasing the chance of developing this complication. Endoscopic retrograde 
pancreatography (ERP) with sphincterotomy or transpapillary stenting should be 
then performed, both in internal and in external fistulae, to reduce resistance of 
pancreatic juice flow to the duodenum [41].
If the disruption is in the body or the tail (disconnected pancreatic tail syndrome), 
open distal pancreatectomy and debridement associated with drainage are the tradi-
tional surgical procedures. These are characterized by a high periprocedural morbid-
ity that is counterweighted by the single procedure and a concise overall course. 
Distal pancreatectomy can be undertaken during the first 30–60 days of illness, in the 
subacute setting [1].
The high morbidity and mortality associated with open surgical procedures, 
especially for poor surgical candidates, recommend a minimally invasive endo-
scopic [42]. Partial duct disruption can be treated with endoscopic transpapillary 
stent bridging with a fistula resolution rate of 56%, according to Varadarajulu et al. 
[43]. One possible endoscopic approach in case of complete duct disruption is the 
use of permanent indwelling transmural stents that allow the creation and mainte-
nance of a fistulous tract into the gastrointestinal lumen [42].
Correct choice of procedure, as well as correct choice of timing of intervention, 
are mandatory for success.
4.  Vascular complications (haemorrhage, pseudoaneurysm and 
thrombosis)
Haemorrhage, pseudoaneurysm and thrombosis are the main vascular complica-
tions with an incidence ranging from 1% to 23% in patients with acute pancreatitis. 
Arterial complications are less frequent than venous complications (1.3-10% vs. 
22%) [44].
The etiopathology of bleeding in patients with severe pancreatitis can be sum-
marized in four main causes. The first one is due to the local spreading of lipolytic 
and proteolytic enzymes during a severe pancreatitis or necrosis that leads to the 
disruption of the tissue and the release of pancreatic fluids thus resulting in the 
arterial wall damage [45]. The second cause is related to a iatrogenic damage: 
improper surgical management of acute pancreatitis with an early operation for 
non-infected necrosis has been reported in Literature as a possible cause of wall 
arterial weakening thus leading to bleeding due to the activated enzymes [46]. 
Another iatrogenic source of damage is associated to the radiological positioning of 
drains that could give a direct trauma to the vessels and a continuous local inflam-
mation that can diminish arterial wall integrity [47]. A third pathogenic mechanism 
is splenic vein thrombosis due to the necrotizing process, pseudocyst and severe 
inflammation that could lead to portal hypertension and, as a late sequelae, to 
esophageal varices formation [45]. The last remarkable pathogenic mechanism is 
the formation of a pseudoaneurysm that derived from the rupture of a vessels into a 
long-standing pseudocyst [48]. Symptoms are gastrointestinal bleeding, abdominal 
pain and splenomegaly and they depend on the localization of pseudoaneurysm. 
The most common vessels are splenic (35-50%), gastroduodenal (20%), and pan-
creaticoduodenal (20%) artery. Other vessels involved are tributaries of the gastric, 
colic and hepatic bloodstream [40, 49].
Ultrasound (US) and Computed Tomography (CT) are the gold standard to 
diagnose a vascular complication. Specially, CT imaging showed a higher sensibility 
in the diagnosis of pseudo-aneurysm, and US has an important role in identifying 
thrombosis or in patients with iodine allergy or renal insufficiency [50]. Enhanced-
contrast CT locates necrotic areas, abscess cavity, pseudocysts, and bleeding site. 
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Angiography is the gold standard technique for the location and the control of the 
bleeding [45]. Interventional radiology is the first line treatment in both elective 
and emergency management of vascular complications. Angiography followed 
by trans-arterial embolization (TAE) is the gold standard management [51]. 
Different techniques can be used: the one preferred is the sandwich technique 
with coil located proximally and distally to the pseudoaneurysm to minimize the 
risk of potential rebleeding [52]. Haemostasis can be implemented with glue, 
N-butyl cyanoacrylate (NBCA), thrombin, ethiodised oil or gelfoam. Patients with 
unsuccessful TAE or in which is technically impossible, an emergency haemostatic 
surgery should be performed. Ligation of bleeding arteries is the technique of 
choice although related to a high rate of rebleeding. In extreme cases, open pack-
ing or salvage emergency pancreatectomy may represent the only chances for 
survival [45].
Vascular complications are rare but potentially fatal with a difficult management 
that is why they should be treated in a tertiary centre.
5. Chylous ascites
Pancreatitis is a rare cause of chylous ascites (CA) and in Literature, only few 
cases about acute pancreatitis are reported since its discovered in 1984 [53, 54]. 
Other causes related to CA are abdominal trauma, malignancies, sarcoidosis, 
lymphangiomatosis, yellow nail syndrome, cirrhosis, and mycobacterial infections 
[55]. CA diagnosis is based on the presence of a milky triglyceride- rich fluid collec-
tion in the peritoneal cavity. Patients complain about abdominal pain, distension, 
weight loss, oedema, anorexia, and weakness.
Diagnosis requires peritoneal fluid sampling with documentation of a lipid 
rich fluid, triglyceride concentration > 1.2 mM (110 mg/dl), peritoneal-to-plasma 
protein concentration ratio of >0.5 and presence of microscopic fat. The minimum 
daily volume of CA considered significant ranges between 100 ml to 600 ml [56, 57].
The pathogenesis is not completely clarified especially when CA is due to acute 
pancreatitis. The main possible reason is the spreading of proteolytic and lipolytic 
enzymes associated to necrosis of pancreatic tissue that damage the lymphatic 
vessels thus provoking a lymph leakage. Other possible reasons are AP related and 
include: splenic vein thrombosis leading to portal vein hypertension thus causing 
the rupture of lymphatic vessels; and the severe inflammation that could cause 
lymphatic vessels obstruction and lymphatic exudation [58, 59].
CA treatment is multimodal. Conservative treatment is based on total parenteral 
nutrition (TPN) or medium chain triglyceride (MCT)-high protein enteral feeding 
with or without addition of octreotide and reaches the resolution in two to six weeks 
in 60-100% of cases [60, 61]. Interventional and surgical approaches should be 
reserved for cases in which conservative treatment has failed. A second line therapy 
is bipedal lymphangiography (BPLAG) with lipiodol. This technique permits to 
identify the normal lymphatic stream and locate the leakage site or the obstruction 
site. The accumulation of injected lipiodol determines an inflammatory response 
that acts as an embolic agent and determines leakage resolution in up to 70% of 
cases [62].
Van der Gaag and colleagues has considered any duration of chylous ascites, 
longer than 14 days despite therapy, a requirement for surgical intervention [63]. 
Surgical treatment may vary from a peritoneovenous shunt to open surgical ligation 
of the leaking lymphatics [64]. Surgical approach should be chosen only in case of 
persistent CA despite treatment, symptomatic patients, or impossibility to perform 
interventional radiology.
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6. Biliary and duodenal complications
Biliary stricture (BS) and duodenal stenosis (DS) are uncommon complication 
of AP. Pathogenesis of these events is strictly related to the anatomical position 
between the pancreatic head, the common bile duct and the duodenum. BS and DS 
are, in most cases, early and transient conditions associated to severe inflammation 
[65]. The main causes for temporary BS are inflammatory oedema and pseudocyst 
formation and enlargement in the area proximal to the pancreatic head that cre-
ate a compression of the common bile duct, thus causing jaundice, nausea, vomit, 
abdominal pain, pruritus, and fatigue to the patient [66].
A duodenal early complication is gastric outlet obstruction related to the abnor-
mal peristaltic wave and following ileus caused by the severe inflammation and the 
possible compression of the duodenal loop by the enlarged neck of the pancreas that 
cause a lumen obstruction [67].
BS ad DS usually solve with a conservative treatment intended to overcome 
the acute inflammatory phase. Pseudocyst management is resumed in previous 
chapters.
In many studies, late BS is associated to pancreatic duct disruption (PDD) with 
pancreatic juice leakage when duct of the head/neck of pancreas is involved in 
pancreatic necrosis [68]. When PDD is suspected, contrast-enhanced CT should be 
performed to confirm it and after that an endoscopic retrograde cholangiopancrea-
tography (ERCP) to localize the leakage and positioning a stent [69]. If this proce-
dure failed, and a progression of the common duct stricture has developed, surgical 
procedure is indicated [53].
The process that leads a transient DS to an irreversible one is still unclear. 
Literature suggests that the underlaying cause is a possible ischemic and thrombotic 
event. Indeed, inflammation may induce arterial narrowing and/or thrombosis 
of the pancreaticoduodenal circulation producing local ischemia and resulting in 
chronic fibrosis [70]. Patients who present intermittent symptomatic episodes of 
upper gastrointestinal tract obstruction should undergo surgical bypass, chosen 
considering the pathophysiology (gastrojejunostomy or gastroenterostomy with 
vagotomy to prevent marginal ulcer)[71].
7. Conclusion
The majority of patients suffering from acute pancreatitis will have a mild, 
self-limited and uncomplicated course. Local and systemic complications, mild or 
life-threatening, such as pancreatic and/or peripancreatic fluid collections, walled-
off necrosis, infected pancreatic necrosis, disconnected pancreatic duct syndrome 
and vascular complications can occur.
The successful management of these patients needs a multidisciplinary team 
composed by gastroenterologists, surgeons, interventional radiologists, and special-
ists in critical care medicine, infectious disease, and nutrition. However, it must be 
considered that the requisite technical expertise and judgment for many of these 
procedures is not widely available in all centres. Intervention is generally required 
for infected pancreatic necrosis and less commonly in patients with sterile necrosis 
who are symptomatic. The surgical odyssey in managing necrotizing pancreatitis 
has been described. Operative approaches to the treatment of acute pancreatitis 
complications have undergone a dramatic transformation over the past few 
decades. Prospective, randomized trials have further clarified the value of the latest 
minimally invasive approaches to the treatment of this disease. This is the notable 
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